Reuters: Health
Japan's "overly restrictive" drug pricing policies risk diverting foreign direct investment to China and other markets, the chief executive of Bristol-Myers Squibb said on Thursday.
Japan drug price reforms risk hurting investment: Bristol-Myers CEO
Japan drug price reforms risk hurting investment: Bristol-Myers CEO
Reuters: Health
Japan's "overly restrictive" drug pricing policies risk diverting foreign direct investment to China and other markets, the chief executive of Bristol-Myers Squibb said on Thursday.
Reuters: Health
Japan's "overly restrictive" drug pricing policies risk diverting foreign direct investment to China and other markets, the chief executive of Bristol-Myers Squibb said on Thursday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment